Singapore markets closed

Tilray Brands, Inc. (TLRY.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
2.3800-0.0900 (-3.64%)
At close: 04:00PM EST
Full screen
Previous close2.4700
Open2.4200
Bid2.3800 x N/A
Ask2.4000 x N/A
Day's range2.3750 - 2.4500
52-week range1.9700 - 4.6400
Volume477,811
Avg. volume1,334,359
Market cap1.797B
Beta (5Y monthly)2.41
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Tilray Provides International Cannabis Update on Milestone German Cannabis Legalization

    Germany’s De-Scheduling of Cannabis Opens Path to New Opportunities for Tilray in Potential $3bn Medical Market European Union Medical Cannabis Market Now Projected to Become $45bn NEW YORK and NEUMÜNSTER, Germany, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today provides an update on Germany’s milestone cannabis legalization and what it means for the future of cannab

  • GlobeNewswire

    Good Supply Launches New ‘Juiced’ Cannabis Pre-Roll Multi-Packs Across Canada

    Featuring Additional Fruity Flavours to the Good Supply FamilyTORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company today announced the latest product releases from its leading Canadian cannabis brand, Good Supply. Good Supply’s new infused GOOD SUPPLY JUICED™ lineup includes its first duo blunt multi-pack with the new 2x1g ‘Cherry on Top’ Blunts and a refreshed

  • GlobeNewswire

    Tilray Medical Applauds German Bundestag and Landmark Passage of Medical Cannabis Act in Germany

    New Medical Cannabis Act in Germany Provides Easier Access to Medical Cannabis for Patients Through the MedCanGCOLOGNE, Germany and NEUMÜNSTER, Germany, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that its medical cannabis division, Tilray Medical, the global leader in medical cannabis, enthusiastically welcomes the opening of the German medical cannabi